Does FIBRINOGEN HUMAN Cause Off label use? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Off label use have been filed in association with FIBRINOGEN HUMAN (TachoSil). This represents 9.3% of all adverse event reports for FIBRINOGEN HUMAN.
38
Reports of Off label use with FIBRINOGEN HUMAN
9.3%
of all FIBRINOGEN HUMAN reports
7
Deaths
10
Hospitalizations
How Dangerous Is Off label use From FIBRINOGEN HUMAN?
Of the 38 reports, 7 (18.4%) resulted in death, 10 (26.3%) required hospitalization, and 6 (15.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FIBRINOGEN HUMAN. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does FIBRINOGEN HUMAN Cause?
Foetal exposure during pregnancy (40)
No adverse event (38)
Drug ineffective (34)
Hypotension (31)
Foetal anaemia (27)
Foetal growth restriction (27)
Haemorrhage in pregnancy (26)
Anaphylactic shock (25)
Maternal exposure during pregnancy (25)
Haemorrhage foetal (24)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FIBRINOGEN HUMAN Alternatives Have Lower Off label use Risk?
FIBRINOGEN HUMAN vs FIBRINOGEN HUMAN\HUMAN THROMBIN
FIBRINOGEN HUMAN vs FIBRINOGEN HUMAN\THROMBIN HUMAN
FIBRINOGEN HUMAN vs FIDAXOMICIN
FIBRINOGEN HUMAN vs FILGOTINIB
FIBRINOGEN HUMAN vs FILGRASTIM